Bloom Energy Corporation Prices Upsized $350.0 Million Green Convertible Senior Notes Offering
SAN JOSE, Calif.–(BUSINESS WIRE)–Bloom Energy Corporation (NYSE:BE) today announced the pricing of its offering of $350.0 million aggregate principal... Read more.
Elliptic Labs Signs Another Expansion License Contract with Top-4 Smartphone Customer Transsion
OSLO, Norway–(BUSINESS WIRE)–#AIVirtualProximitySensor—Elliptic Labs (OSE: ELABS), a global AI software company and the world leader in AI Virtual... Read more.
Innate Pharma Highlights Abstracts Selected for ASCO 2024 Annual Meeting
Top line results of TELLOMAK Phase 2 trial in mycosis fungoides confirming promising clinical activity of lacutamab Two posters on IPH6501, Innate’s second generation... Read more.
Scottish Sensor Technology Startup Novosound Targets Expansion in APAC
Novosound’s Ceilidh system, a wide area corrosion monitoring system for industrial groups seeking to improve efficiency and safety of assets, will be featured... Read more.
Hibiki Path Advisors Submitted Shareholder Proposals at the 53rd Annual General Meeting of Shareholders of Japan Pure Chemical Co., Ltd. Scheduled for June 25th, 2024
TOKYO–(BUSINESS WIRE)–Hibiki Path Advisors (hereinafter referred to as “Hibiki” or “we”), is an asset management company based in Singapore.... Read more.
Kao Releases Progress Reports on its ESG Strategy—the Kirei Lifestyle Plan
Report on Implementation of New Biodiversity, Respect for Human Rights and DE&I Initiatives, Improved Traceability for Palm Oil Procurement, and Impact of ESG... Read more.
iStaging reveals Next Generation MR experiences at VivaTech 2024.
TAIPEI, Taiwan–(BUSINESS WIRE)–iStaging is an innovative Mixed Reality SaaS company driven by computer vision & AI, backed by 10 years of technological... Read more.
Mitsubishi Electric to Establish Vietnamese JV for FA Products
Will initially produce low-voltage circuit breakers for factory-automation products in ASEAN region TOKYO–(BUSINESS WIRE)–Mitsubishi Electric Corporation... Read more.
Celltrion receives European Commission approval of Omlyclo® (CT-P39), the first and only omalizumab biosimilar approved in Europe
Omlyclo® (CT-P39), used to treat allergic asthma, chronic rhinosinusitis with nasal polyps (CRSwNP) and chronic spontaneous urticaria (CSU), becomes the first omalizumab... Read more.
CMBM INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Cambium Networks Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
NEW YORK–(BUSINESS WIRE)–$CMBM #classaction–Attorney Advertising–Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm,... Read more.